[Regulation of reparative processes in glaucoma surgery by collalysin]

Collalysin, a proteolytic enzyme, selectively acting on the young connective tissue, is suggested to be used as part of the complex of measures to prevent excessive cicatrization after antiglaucoma surgery. Rabbit experiments with 3H proline confirm the efficacy of the new drug; a more manifest stable hypotensive effect of antiglaucoma surgery in patients with open-angle glaucoma recommend collalysin for clinical application.